Jun Wang
Chief Executive Officer at Shenzhen iCarbonX Technology Co., Ltd.
Net worth: 196 M $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jamie Heywood | M | - |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA.
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 11 years |
Todd Krueger | M | - |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA.
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 9 years |
William Wayne Colston | M | 56 |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 6 years |
Spiros Jamas | M | 63 |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | 11 years |
Douglas P. Rosefsky | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 6 years |
Annalisa Jenkins | M | 58 |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 6 years |
Lenny Barshack | M | - |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | 11 years |
Walter G. Thompson | M | - |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | 11 years |
Hao Li | M | - |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 9 years |
Jian Hua Wang | M | 70 |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | - |
Song Gang Li | M | 77 |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | - |
Ye Yin | M | 45 |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | - |
Klaus Dugi | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 6 years |
Na Liu | F | - |
BGI Biotech (Shenzhen) Co., Ltd.
BGI Biotech (Shenzhen) Co., Ltd. BiotechnologyHealth Technology BGI Biotech (Shenzhen) Co., Ltd. engages in the conducting of biotechnology. Its business scope includes development, manufacture, and wholesale and retail of medical equipment. The company was founded on November 26, 2013 and is headquartered in Shenzhen, China. | - |
Lauren Ambrogio | F | - |
AOBiome LLC
AOBiome LLC Pharmaceuticals: MajorHealth Technology AOBiome LLC develops and commercializes skin care products. The firm operates an application of AOB that has the potential to restore critical biological and biochemical processes through the symbiotic relationship between humans and this naturally-existing bacteria to address significant clinical need. It has six ongoing clinical programs in acne vulgaris, or acne, allergic rhinitis, migraine, atopic dermatitis, or eczema, rosacea and hypertension, and multiple ongoing preclinical programs, including pulmonary and gastrointestinal disorders. The company was founded by Jamie Heywood, Lenny Barshack, Spiros Jamas, and David Whitlock in 2013 and is headquartered in Cambridge, MA. | 8 years |
Jim Hoffman | M | - |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Chun Wu | M | - |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 3 years |
Ying Rui Li | M | 38 |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 3 years |
Tony Lucia | M | 71 |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 4 years |
Jian Nan Liu | M | - |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | - |
Rui Xin Xiong | M | - |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 4 years |
Yi Fei Mu | M | - |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | - |
Richard Russo | M | 44 |
Shenzhen iCarbonX Technology Co., Ltd.
Shenzhen iCarbonX Technology Co., Ltd. Data Processing ServicesTechnology Services iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China. | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 13 | 56.52% |
United States | 10 | 43.48% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jun Wang
- Personal Network